Jonathan Allan Stoke Therapeutics, Inc. (STOK) insider trading activity
Jonathan Allan is GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc.. Currently has a direct ownership of 21,476 shares of STOK, which is worth approximately $243,108. The most recent transaction as insider was on Dec 09, 2024, when has been sold 13,666 shares (Common Stock) at a price of $13.34 per share, resulting in proceeds of $182,304. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
21.5K
726.64%
3M change
Infinity%
12M change
Total Value Held
$243,108
Jonathan Allan Transaction History
JA
Jonathan Allan
GENERAL COUNSEL & CORP SEC
Bedford, MA